SEC Contract Filing

Filing Date: 2021-02-17

Document Content:
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>9
<FILENAME>d127425dex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION RIGHTS AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS REGISTRATION RIGHTS AGREEMENT (this &#147;<B><I>Agreement</I></B>&#148;), dated as of February&nbsp;11, 2021, is made and entered into by
and among Tishman Speyer Innovation Corp. II, a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), Tishman Speyer Innovation Sponsor II, L.L.C., a Delaware limited liability company (the &#147;<B><I>Sponsor</I></B>&#148;) and the
undersigned parties listed on the signature page hereto under &#147;Holders&#148; (each such party, together with the Sponsor and any person or entity who hereafter becomes a party to this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;5.2</U>
of this Agreement, a &#147;<B><I>Holder</I></B>&#148; and collectively the &#147;<B><I>Holders</I></B>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Company has 8,625,000 shares of Class&nbsp;B common stock, par value $0.0001 per share (after giving effect to a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1.2-for-1</FONT></FONT> forward stock split) (the &#147;<B><I>Founder Shares</I></B>&#148;), issued and outstanding, up to 1,125,000 of which will be forfeited to the Company for no
consideration depending on the extent to which the underwriters of the Company&#146;s initial public offering exercise their over-allotment option; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Founder Shares are convertible into shares of the Company&#146;s Class&nbsp;A common stock, par value $0.0001 per share
(the <B>&#147;</B><B><I>Common</I></B> <B><I>Stock</I></B>&#148;), at the time of the initial Business Combination (as defined below), or earlier at the option of the holder, on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis, subject to adjustment, on the terms and conditions provided in the Company&#146;s amended and restated certificate of incorporation, as may be amended
from time to time; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, on February&nbsp;11, 2021, the Company and the Sponsor entered into that certain Private Placement
Warrants Purchase Agreement (the &#147;<B><I>Private Placement Warrants Purchase Agreement</I></B>&#148;), pursuant to which the Sponsor agreed to purchase 5,333,334 private placement warrants (or up to 5,933,334 warrants to the extent that the
over-allotment option in connection with the Company&#146;s initial public offering is exercised) (the &#147;<B><I>Private Placement Warrants</I></B>&#148;) in a private placement transaction occurring simultaneously with the closing of the
Company&#146;s initial public offering; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, in order to finance the Company&#146;s transaction costs in connection with a
contemplated initial Business Combination, the Sponsor or an affiliate of the Sponsor or the Company&#146;s officers and directors may loan to the Company funds as the Company may require, of which up to $1,500,000 of such loans may be convertible
into private placement-equivalent warrants (&#147;<B><I>Working Capital Warrants</I></B>&#148;) at a price of&nbsp;$1.50 per warrant at the option of the lender; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Company and the Holders desire to enter into this Agreement, pursuant to which the Company shall grant the Holders certain
registration rights with respect to certain securities of the Company, as set forth in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW</B>,<B> THEREFORE</B>, in
consideration of the representations, covenants and agreements contained herein, and certain other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound,
hereby agree as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-1- </P>

</DIV></Center>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1
<U>Definitions</U>. The terms defined in this <I><U>Article I</U></I> shall, for all purposes of this Agreement, have the respective meanings set forth below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Adv